EBITDA Margin ratio Analysis of Tarsus Pharmaceuticals Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-722.97
Period Ending - Dec-22
Very Poor EBITDA Margin
-231.98
Growth
-211.65 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-269.53
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-136.47
EBITDA Margin Analysis of Tarsus Pharmaceuticals Inc
Ebitda Margin Ratio of Tarsus Pharmaceuticals Inc with value of -269.53 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Tarsus Pharmaceuticals Inc with value of -136.47 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of TARS drastically fell by -211.65 % this year. |
EBITDA Margin Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
EBITDA Margin Ratio with value of -722.97 was lowest in Year Dec-23 in last Five Years. |
Latest EBITDA Margin Ratio with value of -722.97 is lower than Average EBITDA Margin of -207.09 in last five years. |
Ebitda Margin of Tarsus Pharmaceuticals Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of TARS that may interest you.
Tarsus Pharmaceuticals Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
TARS | 30.98 | 33.14 | 6.52 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..![EBITDA Margin Formula EBITDA Margin Formula](https://my.stockaio.com/help/template/FinDef/ProfitabilityRatios/EBITDAMargin.jpg)
EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Tarsus Pharmaceuticals Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 |
---|---|---|---|---|---|---|
EBITDA Margin | -722.97 | -231.98 | -0.0213 | -80.47 | 0 | 0 |
Change | -211.65 % | -1088084.68 % | 99.97 % |
FY Chart of EBITDA Margin of Tarsus Pharmaceuticals Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)